高雄醫學大學圖書館 |

Antiviral drugsfrom basic discovery through clinical trials /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Antiviral drugs/ edited by Wieslaw M. Kazmierski.
其他題名:	from basic discovery through clinical trials /
其他作者:	Kazmierski, Wieslaw M.
出版者:	Hoboken, N.J. :Wiley, : c2011.,
面頁冊數:	1 online resource (xiii, 438 p.) :ill. (some col.) :
提要註:	This book focuses on new small molecule approaches to combat viral infections. The chapters describe the discovery and development from bench through the clinic of relatively recently-approved antiviral drugs and compounds in advanced clinical development. Organized by a virus (such as HIV, HCV, RSV, influenza, HBV and CMV) and written by top academic and industrial authorities in the field, the book provides a unique opportunity to study, understand and apply discovery and development principles and learning without the need for an individual to research, analyze and synthesize all immense sourcing references. Topics showcase challenges and solutions of issues encountered, offering tremendous experience accumulated over many years of research that will be particularly useful to basic and bench scientists as well as clinicians as they continue discovering and developing new drugs and therapies.
標題:	Antiviral agents. -
電子資源:	Connect to MyiLibrary resource.
ISBN:	9780470929353 (electronic bk.)

Antiviral drugsfrom basic discovery through clinical trials /
Antiviral drugsfrom basic discovery through clinical trials /[electronic resource] :edited by Wieslaw M. Kazmierski. - Hoboken, N.J. :Wiley,c2011. - 1 online resource (xiii, 438 p.) :ill. (some col.)

Includes bibliographical references and index.

Frontmatter -- Color Plates -- Human Immunodeficiency Virus. Discovery and Development of Atazanavir / Awny Farajallah, R Todd Bunch, Nicholas A Meanwell -- Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor / Jinzi J Wu, Joseph Musto -- Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients / Marie-Pierre de �Bthune, Vanitha Sekar, Sabrina Spinosa-Guzman, Marc Vanstockem, Sandra De Meyer, Piet Wigerinck, Eric Lefebvre -- Discovery and Development of Tipranavir / Karen R Romines -- TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients / Jerome Guillemont, Katia Boven, Herta Crauwels, Marie-Pierre de �Bthune -- Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients / Koen Andries, Ann Debunne, Thomas N Kakuda, Michael Kukla, Ruud Leemans, Johan Vingerhoets, Brian Woodfall, Marie-Pierre de �Bthune -- Discovery and Development of Tenofovir Disoproxil Fumarate / Erik De Clercq -- Discovery and Development of Apricitabine / Susan Cox, John Deadman, Justine Southby, Jonathan Coates -- Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection / Patrick Dorr, Paul Stupple -- Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection / Jayaram R Tagat, Julie M Strizki, Lisa M Dunkle -- Discovery and Development of HIV-1 Entry Inhibitors That Target gp120 / John F Kadow, John Bender, Alicia Regueiro-Ren, Yasutsugu Ueda, Tao Wang, Kap-Sun Yeung, Nicholas A Meanwell -- Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation / Melissa S Egbertson, John S Wai, Mark Cameron, R Scott Hoerrner -- Discovery and Development of HIV Integrase Inhibitor Raltegravir / Vincenzo Summa, Paola Pace -- Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer Inhibitor / Hisashi Shinkai, Masanori Sato, Yuji Matsuzaki -- Hepatitis C Virus. Discovery and Development of Telaprevir / Anne-Laure Grillot, Luc J Farmer, B Govinda Rao, William P Taylor, Ilan S Weisberg, Ira M Jacobson, Robert B Perni, Ann D Kwong -- Discovery and Development of BILN 2061 and Follow-Up BI 201335 / Montse Lli�ns-Brunet, Peter W White -- Intervention of Hepatitis C Replication through NS3-4A, the Protease Inhibitor Boceprevir / Srikanth Venkatraman, F George Njoroge -- Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227) / Scott D Seiwert, Karl Kossen, Lin Pan, Jyanwei Liu, Brad O Buckman -- Discovery and Development of the HCV Protease Inhibitor TMC435 / Pierre Raboisson, Gregory Fanning, Herman de Kock, Asa Rosenquist, Rene Verloes, Kenneth Simmen -- Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection / Klaus Klumpp, David B Smith -- Discovery and Development of PSI-6130/RG7128 / Phillip A Furman, Michael J Otto, Michael J Sofia -- Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV / Kai Lin -- HCV Viral Entry Inhibitors / Flossie Wong-Staal, Guohong Liu, Jeffrey McKelvy -- Respiratory Syncytial Virus Inhibitors. Discovery of the RSV Inhibitor TMC353121 / Jean-Fra�nois Bonfanti, Gabriela Ispas, Frans Van Velsen, Wieslawa Olszewska, Tom Gevers, Dirk Roymans -- Discovery and Development of Orally Active RSV Fusion Inhibitors / Nicholas A Meanwell, Christopher W Cianci, Mark R Krystal -- Discovery and Development of RSV604 / Joanna Chapman, Stuart Cockerill -- Influenza, Hepatitis B, and Cytomegalovirus Inhibitors. Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza / Robin Thomson, Mark von Itzstein -- Discovery and Development of Entecavir / Richard Wilber, Bruce Kreter, Marc Bifano, Stephanie Danetz, Lois Lehman-McKeeman, Daniel J Tenney, Nicholas Meanwell, Robert Zahler, Helena Brett-Smith -- Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus Diseases / Karen K Biron, Kristjan S Gudmundsson, John C Drach -- Index.

This book focuses on new small molecule approaches to combat viral infections. The chapters describe the discovery and development from bench through the clinic of relatively recently-approved antiviral drugs and compounds in advanced clinical development. Organized by a virus (such as HIV, HCV, RSV, influenza, HBV and CMV) and written by top academic and industrial authorities in the field, the book provides a unique opportunity to study, understand and apply discovery and development principles and learning without the need for an individual to research, analyze and synthesize all immense sourcing references. Topics showcase challenges and solutions of issues encountered, offering tremendous experience accumulated over many years of research that will be particularly useful to basic and bench scientists as well as clinicians as they continue discovering and developing new drugs and therapies.

ISBN: 9780470929353 (electronic bk.)

Standard No.: 9786613203632

Source: 320363MILSubjects--Topical Terms:

218271
Antiviral agents.
Index Terms--Genre/Form:

228523
Electronic books.

LC Class. No.: RM411 / .A5753 2011eb

Dewey Class. No.: 615/.7924

National Library of Medicine Call No.: QV 268.5 / A63347 2011

Antiviral drugsfrom basic discovery through clinical trials /
LDR:07144cam 2200541Ma 4500 001 248647
003 OCoLC
005 20120625232958.0
006 m d
007 cr |n|
008 120712s2011 njua ob 001 0 eng d
019 $a 758982153
020 $a 9780470929353 (electronic bk.)
020 $a 0470929359 (electronic bk.)
020 $z 9780470455630 (Cloth)
020 $z 0470455632 (Cloth)
020 $a 9780470929346 (electronic bk.)
020 $a 0470929340 (electronic bk.)
020 $z 9780470934685
020 $z 0470934689
024 8 $a 9786613203632
029 1 $a AU@ $b 000047773982
035 $a (OCoLC)746598445
035 $a ocn746598445
037 $a 320363 $b MIL
040 $a CDX $c CDX $d TXA $d YDXCP $d E7B $d N$T $d EBLCP
049 $a KMCA
050 1 4 $a RM411 $b .A5753 2011eb
060 1 0 $a QV 268.5 $b A63347 2011
072 7 $a MED $x 071000 $2 bisacsh
082 0 4 $a 615/.7924 $2 22
245 0 0 $a Antiviral drugs $h [electronic resource] : $b from basic discovery through clinical trials / $c edited by Wieslaw M. Kazmierski.
260 $a Hoboken, N.J. : $c c2011. $b Wiley,
300 $a 1 online resource (xiii, 438 p.) : $b ill. (some col.)
504 $a Includes bibliographical references and index.
505 0 $a Frontmatter -- Color Plates -- Human Immunodeficiency Virus. Discovery and Development of Atazanavir / Awny Farajallah, R Todd Bunch, Nicholas A Meanwell -- Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor / Jinzi J Wu, Joseph Musto -- Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients / Marie-Pierre de �Bthune, Vanitha Sekar, Sabrina Spinosa-Guzman, Marc Vanstockem, Sandra De Meyer, Piet Wigerinck, Eric Lefebvre -- Discovery and Development of Tipranavir / Karen R Romines -- TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients / Jerome Guillemont, Katia Boven, Herta Crauwels, Marie-Pierre de �Bthune -- Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients / Koen Andries, Ann Debunne, Thomas N Kakuda, Michael Kukla, Ruud Leemans, Johan Vingerhoets, Brian Woodfall, Marie-Pierre de �Bthune -- Discovery and Development of Tenofovir Disoproxil Fumarate / Erik De Clercq -- Discovery and Development of Apricitabine / Susan Cox, John Deadman, Justine Southby, Jonathan Coates -- Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection / Patrick Dorr, Paul Stupple -- Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection / Jayaram R Tagat, Julie M Strizki, Lisa M Dunkle -- Discovery and Development of HIV-1 Entry Inhibitors That Target gp120 / John F Kadow, John Bender, Alicia Regueiro-Ren, Yasutsugu Ueda, Tao Wang, Kap-Sun Yeung, Nicholas A Meanwell -- Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation / Melissa S Egbertson, John S Wai, Mark Cameron, R Scott Hoerrner -- Discovery and Development of HIV Integrase Inhibitor Raltegravir / Vincenzo Summa, Paola Pace -- Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer Inhibitor / Hisashi Shinkai, Masanori Sato, Yuji Matsuzaki -- Hepatitis C Virus. Discovery and Development of Telaprevir / Anne-Laure Grillot, Luc J Farmer, B Govinda Rao, William P Taylor, Ilan S Weisberg, Ira M Jacobson, Robert B Perni, Ann D Kwong -- Discovery and Development of BILN 2061 and Follow-Up BI 201335 / Montse Lli�ns-Brunet, Peter W White -- Intervention of Hepatitis C Replication through NS3-4A, the Protease Inhibitor Boceprevir / Srikanth Venkatraman, F George Njoroge -- Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227) / Scott D Seiwert, Karl Kossen, Lin Pan, Jyanwei Liu, Brad O Buckman -- Discovery and Development of the HCV Protease Inhibitor TMC435 / Pierre Raboisson, Gregory Fanning, Herman de Kock, Asa Rosenquist, Rene Verloes, Kenneth Simmen -- Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection / Klaus Klumpp, David B Smith -- Discovery and Development of PSI-6130/RG7128 / Phillip A Furman, Michael J Otto, Michael J Sofia -- Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV / Kai Lin -- HCV Viral Entry Inhibitors / Flossie Wong-Staal, Guohong Liu, Jeffrey McKelvy -- Respiratory Syncytial Virus Inhibitors. Discovery of the RSV Inhibitor TMC353121 / Jean-Fra�nois Bonfanti, Gabriela Ispas, Frans Van Velsen, Wieslawa Olszewska, Tom Gevers, Dirk Roymans -- Discovery and Development of Orally Active RSV Fusion Inhibitors / Nicholas A Meanwell, Christopher W Cianci, Mark R Krystal -- Discovery and Development of RSV604 / Joanna Chapman, Stuart Cockerill -- Influenza, Hepatitis B, and Cytomegalovirus Inhibitors. Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza / Robin Thomson, Mark von Itzstein -- Discovery and Development of Entecavir / Richard Wilber, Bruce Kreter, Marc Bifano, Stephanie Danetz, Lois Lehman-McKeeman, Daniel J Tenney, Nicholas Meanwell, Robert Zahler, Helena Brett-Smith -- Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus Diseases / Karen K Biron, Kristjan S Gudmundsson, John C Drach -- Index.
520 $a This book focuses on new small molecule approaches to combat viral infections. The chapters describe the discovery and development from bench through the clinic of relatively recently-approved antiviral drugs and compounds in advanced clinical development. Organized by a virus (such as HIV, HCV, RSV, influenza, HBV and CMV) and written by top academic and industrial authorities in the field, the book provides a unique opportunity to study, understand and apply discovery and development principles and learning without the need for an individual to research, analyze and synthesize all immense sourcing references. Topics showcase challenges and solutions of issues encountered, offering tremendous experience accumulated over many years of research that will be particularly useful to basic and bench scientists as well as clinicians as they continue discovering and developing new drugs and therapies.
588 $a Description based on print version record.
650 0 $2 96060 $a Antiviral agents. $3 218271
650 1 2 $2 96060 $a Antiviral Agents $x therapeutic use. $3 219150
650 2 2 $2 96060 $a Clinical Trials as Topic. $3 244058
650 2 2 $a Drug Discovery. $3 301877
650 2 2 $a Drug Evaluation. $3 322640
650 7 $a MEDICAL / Pharmacology $2 bisacsh $3 322644
655 7 $a Electronic books. $2 local $3 228523
700 1 $a Kazmierski, Wieslaw M. $3 322657
856 4 0 $u http://lib.myilibrary.com?id=320363 $z Connect to MyiLibrary resource.
856 4 0 $3 John Wiley $u http://dx.doi.org/10.1002/9780470929353 $z An electronic book accessible through the World Wide Web
856 4 0 $u http://site.ebrary.com/id/10490613 $3 ebrary
856 4 0 $3 EBSCOhost $u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=390121
856 4 0 $z Click here to view book $u http://public.eblib.com/EBLPublic/PublicView.do?ptiID=818637
938 $a Coutts Information Services $b COUT $n 18349244 $c 0.00 GBP
938 $a YBP Library Services $b YANK $n 3537696
938 $a ebrary $b EBRY $n ebr10490613
938 $a EBL - Ebook Library $b EBLB $n EBL818637
994 $a 92 $b KMC
999 $z 634762210347752051